180 related articles for article (PubMed ID: 16450814)
1. Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management.
Rudo TJ; Kowey PR
Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I58-63. PubMed ID: 16450814
[TBL] [Abstract][Full Text] [Related]
2. Practical algorithms for pharmacologic management of the post myocardial infarction patient.
Reiffel JA; ;
Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I28-37. PubMed ID: 16450810
[TBL] [Abstract][Full Text] [Related]
3. Managing the post-myocardial infarction patient with asymptomatic left ventricular dysfunction.
Philippides GJ
Cardiology; 2006; 105(2):95-107. PubMed ID: 16340202
[TBL] [Abstract][Full Text] [Related]
4. Improving the management of patients after myocardial infarction, from admission to discharge.
Amin A
Clin Ther; 2006 Oct; 28(10):1509-39. PubMed ID: 17157110
[TBL] [Abstract][Full Text] [Related]
5. Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy.
Sackner-Bernstein J
Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I19-27. PubMed ID: 16450809
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
Noll G; Kaufmann U; Wenzel RR; Lüscher TF
Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
[TBL] [Abstract][Full Text] [Related]
7. Can antiarrhythmic drugs survive survival trials?
Pratt CM; Waldo AL; Camm AJ
Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
[TBL] [Abstract][Full Text] [Related]
8. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
[TBL] [Abstract][Full Text] [Related]
9. Therapy for acute myocardial infarction.
Rich MW
Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
[TBL] [Abstract][Full Text] [Related]
10. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
11. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.
Abraham WT
Congest Heart Fail; 2008; 14(5):272-80. PubMed ID: 18983291
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
Naccarelli GV; Lukas MA
Clin Cardiol; 2005 Apr; 28(4):165-73. PubMed ID: 15869048
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic therapies after myocardial infarction.
Rapaport E; Gheorghiade M
Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
[TBL] [Abstract][Full Text] [Related]
15. Management of older persons after myocardial infarction.
Aronow WS
J Am Geriatr Soc; 1998 Nov; 46(11):1459-68. PubMed ID: 9809771
[TBL] [Abstract][Full Text] [Related]
16. Hospital protocols and evidence-based therapies: the importance of integrating aldosterone blockade into the management of patients with post-acute myocardial infarction heart failure.
Fonarow GC
Clin Cardiol; 2006 Jan; 29(1):4-8. PubMed ID: 16477770
[TBL] [Abstract][Full Text] [Related]
17. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
Ellison KE; Gandhi G
Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
19. Traditional heart failure medications and sudden cardiac death prevention: a review.
Al Chekakie MO
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):412-26. PubMed ID: 23766358
[TBL] [Abstract][Full Text] [Related]
20. Preventing sudden cardiac death in post myocardial infarction patients with left ventricular dysfunction.
Angerstein RL; Thompson B; Rasmussen MJ
J Cardiovasc Nurs; 2005; 20(6):397-404. PubMed ID: 16485623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
